Stay updated with breaking news from Well Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Innovative subsea intervention solution helps secure Plug Abandonment contract Energy services provider Expro (NYSE: XPRO) has secured a new contract with Harbour Energy for a well abandonment campaign
Revenue of $339 million, down 3% sequentially and up 21% year-over-year Adjusted EBITDA1 of $42 million , down 40% sequentially and up 14% year-over-year. Excluding such LWI-related costs, Adjusted... | May 4, 2023
Expro Group Holdings N.V. (NYSE:NYSE:XPRO) Q2 2022 Earnings Conference Call August 04, 2022 11:00 AM ET Company Participants Karen David-Green - Chief Communication, Stakeholder &...
A Japanese university research team says it has concluded that the world's first clinical trial, spanning over years, transplanting corneal tissues derived from induced pluripotent stem cells, or iPS cells, into four almost-blind patients was safe and effective.
Keio University in Tokyo says it has started the world's first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries.